The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Jefferies has increased its price target for Welltower Inc. to $248 while maintaining a Buy rating, following first-quarter 2026 results that surpassed both revenue and earnings expectations. According to reports, the company experienced a rise in institutional ownership driven by robust performance within the senior housing sector. This upward revision reflects confidence in the company's sustained operational momentum.
Sign in to access this content
Sign InThis bullish outlook arrives as healthcare REITs face a competitive landscape, with market data showing steady performance from peers such as Ventas (VTR). Compared to previous quarters, industry analysts note that occupancy growth and rent hikes in senior housing were primary drivers for Welltower's outperformance, aligning with broader recovery trends in healthcare real estate per industry citations.
Investors are monitoring price levels following this update, with Welltower trading at elevated levels as of the May 15, 2026 close. Looking ahead, market participants are focusing on broader real estate catalysts, including U.S. Existing Home Sales which reached 4.02 million on May 11, 2026. Upcoming speeches from Federal Reserve officials in mid-May will also be critical for assessing interest rate trajectories and their impact on REIT financing costs.